Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyaluronic acid + hydroxypropylmethylcellulose is a composite hydrogel formulation that combines the properties of both polymers. The cross-linked hyaluronic acid provides stability and resistance to degradation, while hydroxypropylmethylcellulose (HPMC) fills the spaces within the cross-linked hyaluronic acid structure, creating a "fence effect" that prevents enzymes like hyaluronidase from degrading the hyaluronic acid. This combination extends the residence time of hyaluronic acid in tissues and enhances the overall stability and biocompatibility of the formulation. The composite has applications in dermal fillers, ocular drug delivery, and wound healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronic acid + hydroxypropylmethylcellulose.